CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) responds poorly to standard chemotherapy or targeted therapy; hence, exploration for novel therapeutic targets is urgently needed. CEP192 protein is indispensable for centrosome amplification, which has been extensively characterized in both hematological malignancies...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanli, Liang, Wanmei, Chang, Yabin, He, Zehui, Wu, Meijian, Zheng, Haozhi, Ke, Xinrong, Lv, Minjia, Liu, Qingqian, Liu, Qinyu, Tang, Waner, Huang, Qiaoling, Lu, Yu, He, Min, Yang, Qijun, Mo, Chunpan, Wang, Jiefan, Peng, Kunwei, Min, Zhiqun, Su, Hang, Chen, Jingqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551108/
https://www.ncbi.nlm.nih.gov/pubmed/36238304
http://dx.doi.org/10.3389/fimmu.2022.950884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551108/
https://www.ncbi.nlm.nih.gov/pubmed/36238304
http://dx.doi.org/10.3389/fimmu.2022.950884

Ejemplares similares